Mezzion Pharmaceuticals Welcomes Dr. Ridwan Shabsigh as New COO to Lead Rare Disease Innovations#USA#Fort_Lee,_NJ#JURVIGO#Mezzion#Ridwan_Shabsigh
Mezzion Pharmaceuticals Welcomes Dr. Ridwan Shabsigh as New COO to Lead Rare Disease Innovations
Dr. Ridwan Shabsigh has been appointed as Mezzion Pharmaceuticals' COO, bringing over 35 years of expertise in drug development and clinical research critical for advancing JURVIGO®.
third-news.com
January 6, 2026 at 2:46 PM
Mezzion Pharmaceuticals Welcomes Dr. Ridwan Shabsigh as New COO to Lead Rare Disease Innovations#USA#Fort_Lee,_NJ#JURVIGO#Mezzion#Ridwan_Shabsigh